MNG387
—
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- —
- cancer_type_detailed
- —
- subtype
- —
GSVA pathway preview (50 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Top 10 elevated
- E2F_TARGETS+0.494
- G2M_CHECKPOINT+0.476
- MYC_TARGETS_V1+0.468
- MYC_TARGETS_V2+0.399
- MITOTIC_SPINDLE+0.319
- UNFOLDED_PROTEIN_RESPONSE+0.311
- MTORC1_SIGNALING+0.305
- INTERFERON_ALPHA_RESPONSE+0.287
- WNT_BETA_CATENIN_SIGNALING+0.285
- DNA_REPAIR+0.217
Top 10 suppressed
- MYOGENESIS-0.264
- ALLOGRAFT_REJECTION-0.207
- BILE_ACID_METABOLISM-0.204
- COAGULATION-0.200
- IL6_JAK_STAT3_SIGNALING-0.193
- HEME_METABOLISM-0.183
- TGF_BETA_SIGNALING-0.170
- KRAS_SIGNALING_UP-0.158
- TNFA_SIGNALING_VIA_NFKB-0.148
- APOPTOSIS-0.136
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
8 twins match this tumor's tissue · 2 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | MNG979 | — | — | 0.847 |
| 2 | BS_P7EY9DXG | ATRT | — | 0.833 |
| 3 | MBCProject_1160_T2_RNA | — | E | 0.820 |
| 4 | E0DE33EA-C3DF-478E-9C4D-86E3C7B3A1D9 | — | — | 0.818 |
| 5 | TCGA-77-8009-01A-11R-2187-07 | — | cohortSQ2 | 0.815 |
| 6 | 9970B75F-7AC6-431B-BDBB-120D01582CBE | — | — | 0.809 |
| 7 | MNG163 | — | — | 0.807 |
| 8 | TCGA-91-6836-01A-21R-1858-07 | — | cohortA1 | 0.801 |
| 9 | BS_B1C6GZ84 | Diffuse intrinsic pontine glioma | — | 0.800 |
| 10 | 592CC5DC-4DB7-4961-AB2B-89C8FE4A83D3 | — | — | 0.797 |